Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies
Mohadeseh Haji Abdolvahab, Pegah Karimi, Nasrin Mohajeri, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives
Jiahao Li, Gong Chen, Haiting Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5489-5489
Open Access | Times Cited: 20
Emerging Applications of Nanoparticles in the Diagnosis and Treatment of Breast Cancer
Josephine B. Oehler, Weranga Rajapaksha, Hugo Albrecht
Journal of Personalized Medicine (2024) Vol. 14, Iss. 7, pp. 723-723
Open Access | Times Cited: 16
Targeting Drug Delivery System to Skeletal Muscles: A Comprehensive Review of Different Approaches
Xiaofang Li, Jintao Xu, Shanshan Yao, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Polydopamine-Coated Zn-MOF-74 Nanocarriers: Versatile Drug Delivery Systems with Enhanced Biocompatibility and Cancer Therapeutic Efficacy
Amir Kazemi, Mohammad Hossein Afshari, Hasan Baesmat, et al.
Journal of Inorganic and Organometallic Polymers and Materials (2024)
Closed Access | Times Cited: 10
Emerging paradigms and recent progress in targeting ErbB in cancers
Nicolas Stoup, Maxime Liberelle, Nicolas Lebègue, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 552-576
Open Access | Times Cited: 5
Computational and Machine Learning Approaches for Optimizing Anti-CD3ε Nanobody: Humanization and Characterization for Enhanced Therapeutic Efficacy
Ali Rahmati Bonab, Hannaneh Jalilzadeh Ghahi, Mahmoud Hassani, et al.
Research Square (Research Square) (2025)
Closed Access
Presence of EGF ligand restricts the binding ability of EgB4 nanobody to EGFR extracellular domain
Duc Toan Truong, Mateusz Chwastyk, Thi Viet, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Near-infrared Photoimmunotherapy: mechanisms, applications, and future perspectives in cancer research
Donald O. Allen, Madeline JoAnna Szoo, Tessa D. van Bergen, et al.
Antibody Therapeutics (2025) Vol. 8, Iss. 1, pp. 68-85
Open Access
A HER2 Specific Nanobody–Drug Conjugate: Site-Selective Bioconjugation and In Vitro Evaluation in Breast Cancer Models
Anders Højgaard Hansen, Kasper Ivert Hentzer Andersen, Xin Li, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 391-391
Open Access
Maytansinoids in cancer therapy: advancements in antibody–drug conjugates and nanotechnology-enhanced drug delivery systems
Matteo Perra, Ines Castangia, Matteo Aroffu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
From antibodies to nanobodies: The next frontier in cancer theranostics for solid tumors
Sanjana Mehrotra, Navdeep Kaur, Sukhpreet Kaur, et al.
Advances in protein chemistry and structural biology (2025)
Closed Access
New developments in the nanocarrier-based drug delivery system for the treatment of breast cancer
Rashid Al‐Yahyai, Jamilah Al Kalbani
Asia-Pacific Journal of Pharmacotherapy & Toxicology (2025), pp. 33-43
Closed Access
Nanoscale warriors against viral invaders: a comprehensive review of Nanobodies as potential antiviral therapeutics
Vaishali Verma, N. D. Sinha, A. Raja
mAbs (2025) Vol. 17, Iss. 1
Open Access
Single domain antibody: Development and application in biotechnology and biopharma
Ting Yu, Fang Zheng, Wenbo He, et al.
Immunological Reviews (2024)
Open Access | Times Cited: 4
Current Status and Future Perspectives of Antibody–Drug Conjugates in Hormone Receptor-Positive Breast Cancer
Maria Grammoustianou, Foteinos‐Ioannis Dimitrakopoulos, Angelos Koutras
Cancers (2024) Vol. 16, Iss. 10, pp. 1801-1801
Open Access | Times Cited: 2
Design, synthesis and bioactivity evaluation of novel monomethyl auristatin F analogues
Lisheng Yang, Xinglin Li, Lei Zhao, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1
Design, synthesis and bioactivity evaluation of novel monomethyl auristatin F analogues
Lisheng Yang, Xinglin Li, Lei Zhao, et al.
Research Square (Research Square) (2024)
Open Access
VHH Nanobody Versatility against Pentameric Ligand-Gated Ion Channels
Dorota Nemecz, Weronika A. Nowak, Ákos Nemecz
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 8502-8518
Open Access
A systematic overview of strategies for photosensitizer and light delivery in antibacterial photodynamic therapy for lung infections
Margarita O. Shleeva, Galina R. Demina, Alexander P. Savitsky
Advanced Drug Delivery Reviews (2024) Vol. 215, pp. 115472-115472
Closed Access
Page 1

Scroll to top